Mirabella Financial Services LLP Ardelyx, Inc. Transaction History

Mirabella Financial Services LLP

  • $1.11 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
SELL
$3.23 - $4.95 $631,913 - $968,413
-195,639 Reduced 53.17%
172,300 $584,000
Q1 2023

May 12, 2023
BUY
$2.68 - $4.79 $886,399 - $1.58 Million
330,746 Added 889.27%
367,939 $1.76 Million
Q4 2022

Feb 13, 2023
BUY
$1.22 - $2.85 $45,375 - $106,000
37,193 New
37,193 $106,000
Q2 2022

Aug 12, 2022
SELL
$0.51 - $1.17 $24,276 - $55,692
-47,600 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$0.65 - $1.18 $30,940 - $56,168
47,600 New
47,600 $51,000

Others Institutions Holding ARDX

# of Institutions
219
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email